Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016

A nationwide cohort study

G. Jermendy, Zoltán Kiss, György Rokszin, Z. Abonyi-Tóth, I. Wittmann, Péter Kempler

Research output: Article

Abstract

Aims: Incidence and prevalence of Type 2 diabetes mellitus (T2DM) vary in different regions. Long-term nationwide epidemiological data are useful to assess trends over time. The aim of the study was to analyze the epidemiological changes of pharmacologically treated T2DM among people aged over 18 years in Hungary between 2001 and 2016. Methods: Annual incidence, prevalence and all-cause mortality rate of pharmacologically treated T2DM patients were evaluated from 2001 to 2016 using the central database of the National Institute of Health Insurance Fund Management. Data were adjusted to age using the 2013 European Standard Population. Results: Incident rate of pharmacologically treated T2DM decreased from 931.6 cases/100,000 person-years to 350.7 cases/100,000 person-years resulting in a −62.4% change (annual average change: −6.46% [95% CI: −7.64%; −5.67%]) between 2001 and 2016. The prevalence rate continuously increased from 4949.9 cases/100,000 persons in 2001 to the highest rate (8135.0 cases/100,000 persons) in 2011, which plateaued during the next 3 years and slightly decreased thereafter. Standardized all-cause mortality rate in people with T2DM decreased between 2001 and 2016 by 11.9% (annual average change: −0.84% [95% CI: −1.22%; −0.39%]). Conclusions: Despite a clearly decreasing incidence of pharmacologically treated T2DM in patients aged over 18 years, the prevalence rate increased from 2001 to 2011 followed by a 3-year-long plateau and a slight decrease thereafter. These long-term trends with the reduced mortality rate may indicate favorable effects of health promotional activities for preventing and treating T2DM.

Original languageEnglish
Article number107788
JournalDiabetes Research and Clinical Practice
Volume155
DOIs
Publication statusPublished - szept. 1 2019

Fingerprint

Hungary
Type 2 Diabetes Mellitus
Cohort Studies
Incidence
Mortality
National Institutes of Health (U.S.)
National Health Programs
Databases
Health
Population

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016 : A nationwide cohort study. / Jermendy, G.; Kiss, Zoltán; Rokszin, György; Abonyi-Tóth, Z.; Wittmann, I.; Kempler, Péter.

In: Diabetes Research and Clinical Practice, Vol. 155, 107788, 01.09.2019.

Research output: Article

@article{cbdd2191e5a1448ca10768aebb58613c,
title = "Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016: A nationwide cohort study",
abstract = "Aims: Incidence and prevalence of Type 2 diabetes mellitus (T2DM) vary in different regions. Long-term nationwide epidemiological data are useful to assess trends over time. The aim of the study was to analyze the epidemiological changes of pharmacologically treated T2DM among people aged over 18 years in Hungary between 2001 and 2016. Methods: Annual incidence, prevalence and all-cause mortality rate of pharmacologically treated T2DM patients were evaluated from 2001 to 2016 using the central database of the National Institute of Health Insurance Fund Management. Data were adjusted to age using the 2013 European Standard Population. Results: Incident rate of pharmacologically treated T2DM decreased from 931.6 cases/100,000 person-years to 350.7 cases/100,000 person-years resulting in a −62.4{\%} change (annual average change: −6.46{\%} [95{\%} CI: −7.64{\%}; −5.67{\%}]) between 2001 and 2016. The prevalence rate continuously increased from 4949.9 cases/100,000 persons in 2001 to the highest rate (8135.0 cases/100,000 persons) in 2011, which plateaued during the next 3 years and slightly decreased thereafter. Standardized all-cause mortality rate in people with T2DM decreased between 2001 and 2016 by 11.9{\%} (annual average change: −0.84{\%} [95{\%} CI: −1.22{\%}; −0.39{\%}]). Conclusions: Despite a clearly decreasing incidence of pharmacologically treated T2DM in patients aged over 18 years, the prevalence rate increased from 2001 to 2011 followed by a 3-year-long plateau and a slight decrease thereafter. These long-term trends with the reduced mortality rate may indicate favorable effects of health promotional activities for preventing and treating T2DM.",
keywords = "Health promotion activities, Incidence, Mortality, Prevalence, Type 2 diabetes",
author = "G. Jermendy and Zolt{\'a}n Kiss and Gy{\"o}rgy Rokszin and Z. Abonyi-T{\'o}th and I. Wittmann and P{\'e}ter Kempler",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/j.diabres.2019.107788",
language = "English",
volume = "155",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016

T2 - A nationwide cohort study

AU - Jermendy, G.

AU - Kiss, Zoltán

AU - Rokszin, György

AU - Abonyi-Tóth, Z.

AU - Wittmann, I.

AU - Kempler, Péter

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Aims: Incidence and prevalence of Type 2 diabetes mellitus (T2DM) vary in different regions. Long-term nationwide epidemiological data are useful to assess trends over time. The aim of the study was to analyze the epidemiological changes of pharmacologically treated T2DM among people aged over 18 years in Hungary between 2001 and 2016. Methods: Annual incidence, prevalence and all-cause mortality rate of pharmacologically treated T2DM patients were evaluated from 2001 to 2016 using the central database of the National Institute of Health Insurance Fund Management. Data were adjusted to age using the 2013 European Standard Population. Results: Incident rate of pharmacologically treated T2DM decreased from 931.6 cases/100,000 person-years to 350.7 cases/100,000 person-years resulting in a −62.4% change (annual average change: −6.46% [95% CI: −7.64%; −5.67%]) between 2001 and 2016. The prevalence rate continuously increased from 4949.9 cases/100,000 persons in 2001 to the highest rate (8135.0 cases/100,000 persons) in 2011, which plateaued during the next 3 years and slightly decreased thereafter. Standardized all-cause mortality rate in people with T2DM decreased between 2001 and 2016 by 11.9% (annual average change: −0.84% [95% CI: −1.22%; −0.39%]). Conclusions: Despite a clearly decreasing incidence of pharmacologically treated T2DM in patients aged over 18 years, the prevalence rate increased from 2001 to 2011 followed by a 3-year-long plateau and a slight decrease thereafter. These long-term trends with the reduced mortality rate may indicate favorable effects of health promotional activities for preventing and treating T2DM.

AB - Aims: Incidence and prevalence of Type 2 diabetes mellitus (T2DM) vary in different regions. Long-term nationwide epidemiological data are useful to assess trends over time. The aim of the study was to analyze the epidemiological changes of pharmacologically treated T2DM among people aged over 18 years in Hungary between 2001 and 2016. Methods: Annual incidence, prevalence and all-cause mortality rate of pharmacologically treated T2DM patients were evaluated from 2001 to 2016 using the central database of the National Institute of Health Insurance Fund Management. Data were adjusted to age using the 2013 European Standard Population. Results: Incident rate of pharmacologically treated T2DM decreased from 931.6 cases/100,000 person-years to 350.7 cases/100,000 person-years resulting in a −62.4% change (annual average change: −6.46% [95% CI: −7.64%; −5.67%]) between 2001 and 2016. The prevalence rate continuously increased from 4949.9 cases/100,000 persons in 2001 to the highest rate (8135.0 cases/100,000 persons) in 2011, which plateaued during the next 3 years and slightly decreased thereafter. Standardized all-cause mortality rate in people with T2DM decreased between 2001 and 2016 by 11.9% (annual average change: −0.84% [95% CI: −1.22%; −0.39%]). Conclusions: Despite a clearly decreasing incidence of pharmacologically treated T2DM in patients aged over 18 years, the prevalence rate increased from 2001 to 2011 followed by a 3-year-long plateau and a slight decrease thereafter. These long-term trends with the reduced mortality rate may indicate favorable effects of health promotional activities for preventing and treating T2DM.

KW - Health promotion activities

KW - Incidence

KW - Mortality

KW - Prevalence

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85069675313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069675313&partnerID=8YFLogxK

U2 - 10.1016/j.diabres.2019.107788

DO - 10.1016/j.diabres.2019.107788

M3 - Article

VL - 155

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

M1 - 107788

ER -